VCEL · Vericel Corp
United States · RS rating 61 · As of 2026-11-03
| Price | 41.09 USD |
|---|---|
| 1-day change | +1.4% |
| RS rating (overall / 1M / 3M / 12M) | 61 / 57 / 47 / 66 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 45 / 37 / 49 |
| Industry group (rank) | Medical-Biomed/Biotech (154) |
| EPS growth Q/Q | +350.0% |
| Sales growth Q/Q | +37.6% |
| Distance from 52-week high | +14.9% |
| Market cap (USD) | $1.8B |